FDA
approval
· 2025-02-11
FDA Approved: BENZTROPINE MESYLATE — Original Application (QUAGEN PHARMACEUTICALS LLC)
Summary
The FDA approved the original application for benztropine mesylate (generic) from Quagen Pharmaceuticals LLC. It is indicated for Parkinson's disease and drug-i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)